Previous Article | Next Article ![]()
Infection and Immunity, May 2000, p. 3002-3006, Vol. 68, No. 5
Center for Pulmonary and Infectious Disease
Control1 and Departments of Cell
Biology3 and
Medicine,4 University of Texas Health
Center, Tyler, Texas 75710, and Immunex Corporation, Seattle,
Washington 981012
Received 22 September 1999/Returned for modification 11 November
1999/Accepted 14 February 2000
Expression of CD40 ligand (CD40L) correlated directly with
Mycobacterium tuberculosis-stimulated gamma interferon
(IFN-
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Depressed CD40 Ligand Expression Contributes to
Reduced Gamma Interferon Production in Human Tuberculosis
) production by peripheral blood mononuclear cells (PBMC) from
tuberculosis patients and healthy tuberculin reactors. The CD40L
agonist increased M. tuberculosis-induced IFN-
production by PBMC, and anti-CD40 or anti-CD40L antibodies reduced
IFN-
production. CD40L expression on PBMC was reduced by exposure to
B cells and to soluble factors from M. tuberculosis-infected monocytes. These findings suggest that
CD40L dysregulation contributes to reduced IFN-
production in human tuberculosis.
*
Corresponding author. Center for Pulmonary and
Infectious Disease Control, The University of Texas Health Center at
Tyler, 11937 U.S. Highway 271, Tyler, TX 75708-3154. Phone: (903)
877-7790. Fax: (903) 877-7989. E-mail: pbarnes{at}uthct.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|